Kanlong Chemical: Subsidiary Kanlong UK invests $30 million in venture fund.

Kanglong Huacheng announced that its wholly-owned subsidiary, Kanglong UK, plans to use its own funds to subscribe for a capital contribution of 30 million US dollars to participate in the investment in BLC Healthcare USD Fund I L.P. The target fundraising amount of the fund is approximately 100 million US dollars, and as of the date of the announcement, Kanglong UK is the largest contributor with a subscription ratio of 85.71%.